Rakuten Kobo

Shopping Cart

Item(s) unavailable for purchase

Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.

itemsitem

- Unlimited access to eBooks
  
  Unlimited access to audiobooks
  
  No commitment, cancel anytime at kobo.com/account/subscriptions
  
  Get 1 credit every month for the audiobook of your choice
  
  No commitment, cancel anytime at kobo.com/account/subscriptions
  
  Unlimited access to eBooks
  
  Unlimited access to audiobooks
  
  No commitment, cancel anytime at kobo.com/account/subscriptions
  Audiobook
  by ,
  
  Available:
  
  . No commitment, cancel anytime at kobo.com/account/subscriptions.
  
  Pre-order
  1 audiobook monthly
  
  + FREE 30-day trial
  
  Special Offer
  
  Get 1 credit every month to exchange for an audiobook of your choice
  
  *No commitment, cancel anytime
  
  FREE

itemsitem

Unlimited access to eBooks

Unlimited access to audiobooks

No commitment, cancel anytime at kobo.com/account/subscriptions

Get 1 credit every month for the audiobook of your choice

No commitment, cancel anytime at kobo.com/account/subscriptions

Unlimited access to eBooks

Unlimited access to audiobooks

No commitment, cancel anytime at kobo.com/account/subscriptions
Audiobook
by ,

Available:
. No commitment, cancel anytime at kobo.com/account/subscriptions.

Pre-order
1 audiobook monthly

+ FREE 30-day trial

Special Offer

Get 1 credit every month to exchange for an audiobook of your choice

*No commitment, cancel anytime

FREE

Recommended For You

Skip side bar filters

The Right Price

A Value-Based Prescription for Drug Costs

by Peter J. Neumann, Joshua T. Cohen, Daniel A. Ollendorf ...

The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the ... Read more

$46.79 USD

The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the
... Read more

Redefining Health Care

Creating Value-based Competition on Results

by Michael E. Porter, Elizabeth Olmsted Teisberg ...

The U.S. health care system is in crisis. At stake are the quality of care for millions of Americans and the financial well-being of individuals and employers squeezed by skyrocketing premiums—not to mention the stability of state and federal government budgets.In Redefining Health Care, internationally renowned strategy expert Michael Porter and innovation expert Elizabeth Teisberg reveal the ... Read more

$32.39 USD or Free with Kobo Plus

The U.S. health care system is in crisis. At stake are the quality of care for millions of Americans and the financial well-being of individuals and employers squeezed by skyrocketing premiums—not to mention the stability of state and federal government budgets.In Redefining Health Care, internationally renowned strategy expert Michael Porter and innovation expert Elizabeth Teisberg reveal the
... Read more
Introduction To Health Economics

by Lorna Guinness, Virginia Wiseman ...

This practical text offers the ideal introduction to the economic techniques used in public health. ... Read more

$42.29 USD

This practical text offers the ideal introduction to the economic techniques used in public health.
... Read more
Side Effects

How Our Healthcare Lost Its Way – And How We Fix It

by David Haslam ...

In the shadow of the pandemic , how do we make a healthcare system that is affordable, effective and fair? With a single drug in the UK currently costing £ 340,000 per patient per year, or a gene therapy in the USA being costed at $1.2million, who should get such treatments, and how can we begin to afford them? Should we all be entitled to timely mental health therapy? How should we care for our ... Read more

$11.99 USD or Free with Kobo Plus

Also available as: Audiobook

In the shadow of the pandemic , how do we make a healthcare system that is affordable, effective and fair? With a single drug in the UK currently costing £ 340,000 per patient per year, or a gene therapy in the USA being costed at $1.2million, who should get such treatments, and how can we begin to afford them? Should we all be entitled to timely mental health therapy? How should we care for our
... Read more

Also available as: Audiobook
Sickening

How Big Pharma Broke American Health Care and How We Can Repair It

by John Abramson ...

The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world. At the heart of ... Read more

$7.99 USD

Also available as: Audiobook

The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world. At the heart of
... Read more

Also available as: Audiobook
Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services

by Les Funtleyder ...

Is your portfolio in peak health?Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for ... Read more

$48.99 USD

Is your portfolio in peak health?Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for
... Read more
Principles of Pharmaceutical Marketing

by Mickey C. Smith Ph.D. ...

Principles of Pharmaceutical Marketing, Third Edition offers the perspectives of both those who teach and those who practice pharmaceutical marketing. This reflects the need for and the effort to provide the most relevant “real world” approach to this complex and fascinating field. This text is designed for undergraduate students in pharmacy whose background in marketing is limited, those actually ... Read more

$64.99 USD

Principles of Pharmaceutical Marketing, Third Edition offers the perspectives of both those who teach and those who practice pharmaceutical marketing. This reflects the need for and the effort to provide the most relevant “real world” approach to this complex and fascinating field. This text is designed for undergraduate students in pharmacy whose background in marketing is limited, those actually
... Read more
Pharmaceutical Market Access in Developed Markets

by Güvenç Koçkaya, Albert Wertheimer ...

Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization.It covers a group of activities intended to provide access to the appropriate medicine for the ... Read more

$10.99 USD or Free with Kobo Plus

Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization.It covers a group of activities intended to provide access to the appropriate medicine for the
... Read more
Understanding Health Policy, 7E

by Thomas S. Bodenheimer, Kevin Grumbach ...

Understand how the healthcare system works – and how you can succeed in itA Doody's Core Title for 2019!The Seventh Edition of Understanding Health Policy: A Clinical Approach remains the most trusted and comprehensive guide to healthcare available and provides everything you need to build a solid foundation on the field’s most critical issues. This concise and engaging textbook clearly explains ... Read more

$36.49 USD

Understand how the healthcare system works – and how you can succeed in itA Doody's Core Title for 2019!The Seventh Edition of Understanding Health Policy: A Clinical Approach remains the most trusted and comprehensive guide to healthcare available and provides everything you need to build a solid foundation on the field’s most critical issues. This concise and engaging textbook clearly explains
... Read more
From Breakthrough to Blockbuster

The Business of Biotechnology

by Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos ...

Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these ... Read more

$25.69 USD

Also available as: Audiobook

Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these
... Read more

Also available as: Audiobook
The Patient Priority: Solve Health Care's Value Crisis by Measuring and Delivering Outcomes That Matter to Patients

by Stefan Larsson, Jennifer Clawson, Josh Kellar ...

From the thought leaders at Boston Consulting Group come lessons on how leading health systems around the world are delivering patient-centered, value-based care by focusing on the health outcomes that matter to patients.To address the growing crises confronting the global health sector, health systems need to deliver better health outcomes to patients for the money spent, an approach known as ... Read more

$23.09 USD

From the thought leaders at Boston Consulting Group come lessons on how leading health systems around the world are delivering patient-centered, value-based care by focusing on the health outcomes that matter to patients.To address the growing crises confronting the global health sector, health systems need to deliver better health outcomes to patients for the money spent, an approach known as
... Read more
Handbook of Health Economics

Edited by Mark V. Pauly, Pedro Pita Barros, Thomas G. McGuire ...

Series Book 2 - Handbooks in Economics
What new theories, evidence, and policies have shaped health economics in the 21st century? Editors Mark Pauly, Thomas McGuire, and Pedro Pita Barros assemble the expertise of leading authorities in this survey of substantive issues. In 16 chapters they cover recent developments in health economics, from medical spending growth to the demand for health care, the markets for pharmaceutical products ... Read more

$143.99 USD

What new theories, evidence, and policies have shaped health economics in the 21st century? Editors Mark Pauly, Thomas McGuire, and Pedro Pita Barros assemble the expertise of leading authorities in this survey of substantive issues. In 16 chapters they cover recent developments in health economics, from medical spending growth to the demand for health care, the markets for pharmaceutical products
... Read more

Rakuten Kobo

eReaders

Apps

Accessories

What is Kobo Super Points?

Reward Yourself

Shopping Cart

You're getting the VIP treatment!

Your Shopping Cart is empty

Available:

1 audiobook monthly

+ FREE 30-day trial

Available:

1 audiobook monthly

+ FREE 30-day trial

Recommended For You

“daniel a ollendorf”

The Right Price

People who read this also enjoyed

Redefining Health Care

Introduction To Health Economics

Side Effects

Sickening

Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services

Principles of Pharmaceutical Marketing

Pharmaceutical Market Access in Developed Markets

Understanding Health Policy, 7E

From Breakthrough to Blockbuster

The Patient Priority: Solve Health Care's Value Crisis by Measuring and Delivering Outcomes That Matter to Patients

Handbook of Health Economics

eReaders

Apps

Accessories

Shopping Cart

You're getting the VIP treatment!

Your Shopping Cart is empty

Available:

1 audiobook monthly

+ FREE 30-day trial

Available:

1 audiobook monthly

+ FREE 30-day trial

Recommended For You

“daniel a ollendorf”

Show:

People who read this also enjoyed